Sign in
4

Changes in Ownership

Structure Therapeutics Inc. Filed Acc 0001962926-26-000009

CHIEF SCIENTIFIC OFFICER acquired 17,817 shares (option exercise)

  • CHIEF SCIENTIFIC OFFICER acquired 17,817 shares (conversion)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Option exercise 10b5-1 +17,817 $0.34 $6,058 246,777 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Conversion 10b5-1 −17,817 228,960 D
Derivatives
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Option exercise · Share Option (right to buy) 10b5-1 −17,817 125,081 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Conversion · American Depositary Shares 10b5-1 +5,939 5,939 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Sale · American Depositary Shares 10b5-1 −1,300 $45.86 $59,623 4,639 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Sale · American Depositary Shares 10b5-1 −4,539 $47.20 $214,254 100 D
Lin Xichen CHIEF SCIENTIFIC OFFICER 2026-09-01 Sale · American Depositary Shares 10b5-1 −100 $47.83 $4,783 0 D
Loading xslF345X06/form4-09032026_010924.xml…